Shanghai Sunve Pharmaceutical Co., Ltd.

With the advantages in qualities, technologies and administrations, Sunve is devoting to develop four series of pharmaceuticals including anti-infections, cardio-/cerebro-vascular, immunity system, anti-tumor. And Sunve has created and marketed bulk pharmaceuticals, prescriptions, bioengineering products, intermediates, health care products.

Activity:

- Contract Manufacturing
- Licensing & Business Development
- Manufacturing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- API / chemicals
- Drug delivery
- FP (finished products)
- Nutritionals / Vitamins
- Prescription drugs (Rx)

Therapeutic targets:

- Arthritis / Rheumato
- Cancer
- Cardiovascular
- Central nervous system
- Dermatology
- Diabetes
- Infectious Diseases
- Oncology
- Urology
- Women's Health

Markets Covered

a. HeadQuarter: China

b. Continent(s) active: North America , Europe , Asia

c. Countries active: US, EU,

Corporate data:

Number of Employees: 1400

Turnover:

Amount:	Year:	Currency:
50,000,000	2002	US Dollar

Year founded: 1958